Coronary Disease/Myocardial Infarction
RSSArticles
-
The Limits of Shortened Antiplatelet Therapy in Acute Coronary Syndrome
One month of dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy did not meet criteria for noninferiority vs.12 months of DAPT for a composite endpoint of ischemic and bleeding events.
-
Vitamin and Mineral Supplements for Cardiovascular Disease
A meta-analysis of systematic reviews and randomized, controlled trials to analyze the role of commonly used dietary supplements for prevention and treatment of cardiovascular disease suggests no significant effect on cardiovascular outcomes or all-cause mortality, although some B vitamins appear to reduce stroke incidence, and B3 appears to increase all-cause mortality.
-
The Difficulty of Showing Benefit of Cerebral Protection Devices During TAVR
In this trial of cerebral protection in transcatheter aortic valve replacement, the TriGUARD device was safe vs. historical controls, but failed to meet its primary efficacy endpoint. -
Another Way Antibiotic Therapy Can Kill You
An analysis revealed fluoroquinolone antibiotic use was associated with later aortic diseases and mortality in patients without known aortic disease.
-
Another Agent for Hypercholesterolemia
A pooled analysis of three trials of inclisiran in patients with atherosclerotic cardiovascular disease or its risk equivalent showed impressive reductions in LDL cholesterol with subcutaneous injections. -
Importance of Atherosclerotic Disease Risk Factors in Myocardial Infarction Patients
ST-elevation myocardial infarction patients without standard risk factors recorded a higher all-cause mortality rate that was particularly evident in women. Using proper therapy in these patients may attenuate this risk. -
Predicting Coronary Artery Disease in Breast Cancer Patients
The authors applied an automated algorithm to calculate an Agatston coronary artery calcium score from non-ECG-gated planning CT scans in breast cancer patients undergoing radiation therapy. This provided a graded risk calculation that could encourage preventive measures in patients at highest risk of a cardiovascular disease event. -
FFR Fails to Show Benefit in Treatment of Nonculprit Lesions After STEMI
In this study of patients presenting with ST-elevation myocardial infarction and multivessel disease, nonculprit vessel percutaneous coronary intervention (PCI) guided by fractional flow reserve failed to show benefit vs. angiography-guided PCI in terms of clinical events at one year. -
Acute Myocardial Infarction Most Likely to Result in Payout
Almost 40% of acute myocardial infarction malpractice claims result in payment, a higher percentage than any other condition, according to the results of a recent analysis. -
STEMI in Post-Transcatheter Aortic Valve Replacement Patients
This large series of post-transcatheter aortic valve replacement patients with ST-elevation myocardial infarction demonstrates elevated rates of percutaneous coronary intervention failure and high short- and intermediate-term mortality rates.